About the LGR

Uniting CRISPR pioneers with industry expertise to help unravel mysteries of the human genome

Get to know us

"The LGR is about building that space where creative science is partnered with the development of robust technology that will help develop tomorrow’s drugs." — Dr. Jennifer Doudna
The Laboratory for Genomics Research (LGR) is a novel hybrid model that brings together drug discovery and academic researchers under a single roof working on projects both together and independently. The outputs of these research projects will be focused on technologies, new drug targets and biological mechanisms that will help foster both academic and industrial advances. The LGR will push the boundaries of functional genomics research and also create next-generation technologies that will become future standard practice.
Fyodor Urnov in panel

What we're about

Our Vision

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna.

Our Mission

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna.

Our Values

1. Lorem ipsum dolor sit amet, consectetur adipiscing.

2. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

3. Duis aute irure dolor in reprehenderit in voluptate.

4. Lorem ipsum dolor sit amet, consectetur adipiscing.

5. Ut enim ad minim veniam, quis nostrud exercitation. Duis aute irure dolor in reprehenderit in voluptate.
Joining forces to advance genomic research and improve drug discovery
Learn more about who we are, what we do, and why we do it.

The Start

The LGR is the brainchild of Professor Jennifer Doudna, UCB, a co-inventor of CRISPR technology and HHMI Investigator, 2020 Nobel Prize Laureate in Chemistry; Professor Jonathan Weissman, UCSF, a pioneer of CRISPR screening technology and HHMI Investigator; and Dr. Hal Barron, Chief Scientific Officer and President, R&D, GSK. The five-year collaboration to establish a state-of-the-art laboratory for CRISPR technologies was announced in June 2019. Since our founding, we have set in motion several collaborative projects between UC & GSK across different disease areas as well as funded multiple independent university research projects at both UCSF and UC Berkeley.
Jennifer Doudna and Dr. Hal Barron

Our Founders

Jennifer Doudna
CRISPR Co-Inventor, UC Berkeley Professor of Biochemistry, Biophysics & Structural biology, 2020 Nobel Prize Laureate in Chemistry
Dr. Hal Barron
GSK Chief Scientific Officer and President of R&D
Jonathan Weissman
MIT Professor of Biology, Member of Whitehead Institute

Partners

UCSF Logo
UC San Francisco (UCSF) is a leading university dedicated to promoting health worldwide through advanced biomedical research, graduate-level education in the life sciences and health professions, and excellence in patient care.
GSK Logo
GSK is a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer. At GSK, we’re bringing together great science, new tech, and outstanding people with the goal of doubling our development success rate to make a difference in more patients’ lives.
UC Berkeley Logo
UCB is the world’s premier public university with a mission to excel in teaching, research and public service. This mission has led to the university's distinguished record of world-class scholarship, innovation, concern for the betterment of our world, and top rankings for its schools and departments.
Explore Open Positions

Join academic & industry researchers to push the boundaries of functional genomics